MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy

NCT00660543 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Adult Brain Glioblastoma

Interventions

DRUG: Gadolinium
DRUG: Ferumoxytol Non-Stoichiometric Magnetite
OTHER: Dynamic Contrast-Enhanced Magnetic Resonance Imaging
OTHER: Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging
OTHER: Diffusion Weighted Imaging
OTHER: MRI-Based Angiogram

Sponsor

OHSU Knight Cancer Institute

Collaborators

[object Object]